Back
Y-mAbs Therapeutics Vs. Puma Biotechnology Industry Stock Comparison
Sell
35
YMAB
Y-mAbs Therapeutics
Last Price:
12.85
Seasonality Move:
18.11%
Buy
56
PBYI
Puma Biotechnology
Last Price:
4.80
Seasonality Move:
31.31%
Sell
35
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy, Sell or Hold?
- The current Y-mAbs Therapeutics [YMAB] share price is $12.87. The Score for YMAB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Puma Biotechnology (PBYI)
is a Buy
Is Puma Biotechnology a Buy, Sell or Hold?
- The current Puma Biotechnology [PBYI] share price is $4.79. The Score for PBYI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PBYI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
YMAB Stock Price Chart
What is Y-mAbs Therapeutics's stock price today?
-
The Y-mAbs Therapeutics share price today is $12.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.
PBYI Stock Price Chart
What is Puma Biotechnology's stock price today?
-
The Puma Biotechnology share price today is $4.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBYI is experiencing selling pressure, which indicates risk of future bearish movement.
YMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 34.3 | Sell |
| Chaikin Money Flow: | -507827 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.03 - 16.29) | Sell |
| Bollinger Bands (100): | (9.68 - 16.9) | Sell |
PBYI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 41.8 | Sell |
| Chaikin Money Flow: | -142106 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.81 - 5.41) | Sell |
| Bollinger Bands (100): | (4.49 - 5.89) | Sell |
YMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.88 | Sell |
| 20-day SMA: | 15.38 | Sell |
| 50-day SMA: | 15.62 | Sell |
| 200-day SMA: | 9.42 | Buy |
| 8-day EMA: | 15.23 | Sell |
| 20-day EMA: | 15.4 | Sell |
| 50-day EMA: | 14.97 | Sell |
| 200-day EMA: | 11.21 | Buy |
PBYI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.85 | Sell |
| 20-day SMA: | 4.99 | Sell |
| 50-day SMA: | 5.23 | Sell |
| 200-day SMA: | 4.24 | Buy |
| 8-day EMA: | 4.84 | Sell |
| 20-day EMA: | 4.98 | Sell |
| 50-day EMA: | 5.14 | Sell |
| 200-day EMA: | 4.53 | Buy |
Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.27 per share.
Puma Biotechnology Earnings Growth & PBYI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.11 per share.
Y-mAbs Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Puma Biotechnology Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||